Serendipity in discovery of proteasome inhibitors.
2012
Abstract Among its various catalytic activities, the ‘chymotrypsin-like’ activity of the proteasome, a large multicatalytic proteinase complex has emerged as the focus of drug discovery efforts in cancer therapy. Herein, a series of first generation (2 S , 3 R )-2-amino-3-hydroxybutyric acid derived proteasome inhibitors that were discovered serendipitously en route to original goal of generating a series of sterically constrained oxazoline derivatives has been reported.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
26
References
6
Citations
NaN
KQI